{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:35Z","timestamp":1789924775832,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jneuroim.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T02:47:42Z","timestamp":1452134862000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Disease specific enrichment of circulating let-7 family microRNA in MuSK + myasthenia gravis"],"prefix":"10.1016","volume":"292","author":[{"given":"Tanel","family":"Punga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-8661","authenticated-orcid":false,"given":"Emanuela","family":"Bartoccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-9413","authenticated-orcid":false,"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.01.003_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia gravis: paradox versus paradigm in autoimmunity","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0015","doi-asserted-by":"crossref","first-page":"e43812","DOI":"10.1371\/journal.pone.0043812","article-title":"Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151","volume":"7","author":"Chiyomaru","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/IGC.0b013e31828c166d","article-title":"Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients","volume":"23","author":"Chung","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ni.3036","article-title":"TLR7 induces anergy in human CD4(+) T cells","volume":"16","author":"Dominguez-Villar","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: a new source of biomarkers","volume":"717","author":"Etheridge","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0045","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0055","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1212\/NXI.0000000000000077","article-title":"Characterization of B cells in muscle-specific kinase antibody myasthenia gravis","volume":"2","author":"Guptill","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1101\/gad.215376.113","article-title":"Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts","volume":"27","author":"Gurtan","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0065","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells","volume":"14","author":"Jiang","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","article-title":"Biomarker development for myasthenia gravis","volume":"1275","author":"Kaminski","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0090","doi-asserted-by":"crossref","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03262205","article-title":"The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis","volume":"16","author":"Krell","year":"2012","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development, function and ageing","volume":"144","author":"Kroesen","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0120","doi-asserted-by":"crossref","first-page":"e87308","DOI":"10.1371\/journal.pone.0087308","article-title":"The miRNA plasma signature in response to acute aerobic exercise and endurance training","volume":"9","author":"Nielsen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0130","doi-asserted-by":"crossref","first-page":"e91927","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0135","doi-asserted-by":"crossref","first-page":"e13247","DOI":"10.1371\/journal.pone.0013247","article-title":"Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line","volume":"5","author":"Ohshima","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.stemcr.2014.08.015","article-title":"Let-7 miRNAs can act through notch to regulate human gliogenesis","volume":"3","author":"Patterson","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0160","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1183\/09031936.00029610","article-title":"Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival","volume":"37","author":"Silva","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0170","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/CIRCRESAHA.110.218297","article-title":"MiR423-5p as a circulating biomarker for heart failure","volume":"106","author":"Tijsen","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/gene.2010.53","article-title":"Let-7\/miR-98 regulate Fas and Fas-mediated apoptosis","volume":"12","author":"Wang","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0180","doi-asserted-by":"crossref","first-page":"e0123546","DOI":"10.1371\/journal.pone.0123546","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yilmaz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jneuroim.2016.01.003_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","article-title":"The Lin28\/let-7 axis regulates glucose metabolism","volume":"147","author":"Zhu","year":"2011","journal-title":"Cell"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:05Z","timestamp":1759047965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816300042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":38,"alternative-id":["S0165572816300042"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}